The concomitant utilization of oxycodone HCl with all cytochrome P450 3A4 inhibitors could lead to an increase in oxycodone plasma concentrations, which could boost or prolong adverse reactions and may result in perhaps deadly respiratory depression. Also, discontinuation of the concomitantly used c